FDA
-
-
-
-
-
-
-
enVVeno receives unfavorable FDA appeal decision for VenoValve device
-
-
-
-
-
-
-
enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)
-
-
-
-
-
-
-
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
-
-
-
-
-
-
-
One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum
-
-
-
-
-
-
-
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
-
-
-
-
-
-
-
enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
enVVeno Medical (NVNO) Reports New Topline Efficacy Data from VenoValve Trial
-
323,152 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

